There is no single blood, urine, or at-home test that can confirm perimenopause. Clinicians usually identify it from a pattern of menstrual-cycle changes, symptoms, age, medical history, and selected tests when another explanation needs to be considered. Menopause is defined retrospectively after 12 consecutive months without a menstrual period when no other cause explains the change. 1 2
Wondering if hormone therapy is right for you? Take the 3-min clinical quiz.
See if you qualify →Can a test tell you if you are in perimenopause?
Usually, no. A single hormone test cannot confirm perimenopause because ovarian hormone production becomes less predictable during the transition. For people age 45 or older with typical cycle changes and symptoms, guidance generally supports a clinical evaluation rather than routine testing to diagnose perimenopause. 1 2
Why perimenopause is evaluated as a pattern, not a single lab result
Perimenopause is the time leading up to menopause, when ovulation and menstrual cycles become less regular. Estradiol, a main form of estrogen made by the ovaries, may rise and fall rather than decline in a straight line. Progesterone production can also change when ovulation becomes inconsistent. That biology is why a result that appears “normal” or “high” on one day does not rule perimenopause in or out. 3
A clinician may ask when periods changed, whether bleeding is heavier or lighter, and whether there are hot flashes, sleep disruption, mood changes, vaginal symptoms, or other concerns. Our guide to hormone changes in perimenopause explains why these changes can feel uneven rather than gradual.
Perimenopause versus menopause
Perimenopause and menopause are related but not interchangeable. Menopause is reached after 12 months without a menstrual period, assuming pregnancy, medications, surgery, and other health conditions do not explain the absence of periods. Perimenopause can last for years before that point and often includes changing cycle length or flow. 1 2
What do perimenopause and at-home menopause tests measure?
Most tests marketed for menopause measure follicle-stimulating hormone (FSH), either in blood or urine. FSH is made by the pituitary gland and signals the ovaries. It often rises as ovarian function changes, but it can vary enough during perimenopause that one result has limited diagnostic value. 2 3
| Test or marker | What it measures | What it can and cannot tell you |
|---|---|---|
| Urine FSH home kit | FSH detected in urine | May show that FSH is elevated at the time of testing. It cannot independently diagnose perimenopause or menopause because FSH varies. 2 |
| Blood FSH | FSH concentration in blood | May help in selected clinical circumstances, especially for people under 45 with possible early menopause symptoms. It needs clinical context. 2 |
| Blood estradiol | Estradiol, a form of estrogen | Shows a value at one point in time. Estradiol can fluctuate during the transition, so it is not a stand-alone perimenopause test. 3 |
| Other laboratory tests | Tests chosen for a specific concern, such as thyroid or pregnancy testing | May help evaluate other possible causes of symptoms or missed periods. The right tests depend on history and symptoms. 2 5 |
Why one result may not answer the question
A high FSH result does not automatically mean you have reached menopause, and a lower result does not exclude perimenopause. Hormonal birth control, some medical conditions, pregnancy possibility, and the timing of a test can also affect how a result is interpreted. This is especially important if you have had a hysterectomy, because bleeding patterns are no longer available as a clue. 1 2
An at-home test can be a prompt to start a conversation, but it should not replace care for bothersome symptoms, missed periods with possible pregnancy, or unusual bleeding. If you already have results, estradiol levels can be useful to discuss with a clinician in the context of the full picture.
What signs can help a clinician evaluate perimenopause?
The most helpful clues are often changes in your usual menstrual pattern plus symptoms that occur over time. Perimenopause looks different from person to person: some people notice cycle changes first, while others first notice sleep disruption or hot flashes. 1 4
Changes in timing or flow
Periods may come closer together, farther apart, or become harder to predict. Flow may also change. Any new heavy bleeding, bleeding between periods, bleeding after sex, or bleeding that affects daily life should be reviewed promptly, because these changes can have causes beyond perimenopause. 5
Hot flashes, night sweats, and other symptoms
Hot flashes and night sweats are called vasomotor symptoms. They can interrupt sleep and affect daytime energy or concentration. Vaginal dryness, discomfort with sex, urinary symptoms, sleep changes, and mood changes may also occur, but each has other possible explanations. 4 6
A practical record to bring to an appointment
- Track the first day of each period, cycle length, and changes in flow.
- Note hot flashes, night sweats, sleep changes, mood symptoms, vaginal symptoms, and how much they disrupt daily life.
- List medications, supplements, contraception, and any hormone treatment.
- Record pregnancy possibility when relevant, plus family history and major health changes.
- Bring home-test results if you have them, but include the date and your cycle timing.
A tracker does not diagnose perimenopause. It does make it easier for a clinician to see patterns and discuss options. For a broader symptoms overview, see perimenopause versus menopause symptoms.
3-min quiz
Talk through symptoms, not just one number
At Chia, a licensed US provider can review your symptoms, menstrual history, medications, and health history online to determine whether treatment options may be clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Chia medications are compounded by state-licensed US 503A pharmacies and are not FDA-approved.
When might hormone or other lab testing be useful?
Testing can be useful when the history is unclear, symptoms begin unusually early, or another condition may be contributing. Testing is selective, not routine, and its meaning depends on the question a clinician is trying to answer. 2
For example, clinicians may consider testing in people under 45 with symptoms suggestive of menopause, in people whose periods cannot be assessed because of hysterectomy or certain contraceptives, or when pregnancy, thyroid disease, anemia, or another condition is possible. The test plan should follow the person’s symptoms, medications, and medical history rather than a standard online panel. 2 5
What can be mistaken for perimenopause?
Several concerns can overlap with perimenopause symptoms, so it is important not to assume that every hot flash or irregular period has the same cause. Sleep disorders, thyroid conditions, medication effects, mood disorders, pregnancy, and gynecologic causes of abnormal bleeding may need consideration based on your history and symptoms. 2 5
What options can help when perimenopause symptoms are disruptive?
Care should focus on the symptoms affecting your life, your goals, and your health history. Shared decision-making matters because hormonal and nonhormonal options have different benefits, risks, and contraindications. 6 8
For bothersome vasomotor symptoms, a clinician may discuss menopausal hormone therapy or nonhormonal prescription options, depending on the person’s history and preferences. Systemic hormone therapy is not appropriate for everyone; important considerations can include a history of estrogen-sensitive cancer, unexplained vaginal bleeding, blood clots, stroke, liver disease, or other individual risk factors. 6 8
Estradiol withdrawal has also been studied in relation to mood in a specific group: in a randomized trial of women with a history of perimenopausal depression, estradiol withdrawal was associated with recurrence of depressive symptoms in some participants. That result does not mean mood changes are always caused by hormones or that estradiol is appropriate for every person with mood symptoms. 7
Sleep habits, regular movement, reducing alcohol when it triggers symptoms, and mental health support may also be part of a care plan. These approaches do not replace evaluation of new or concerning symptoms, and their usefulness varies by symptom and person. 6
How does perimenopause care work at Chia?
At Chia, online care starts with a health questionnaire and a review by a licensed US provider. Treatment eligibility is individualized: the provider considers symptoms, menstrual history, medications, pregnancy possibility where relevant, and medical history rather than making a decision from a single hormone result. A prescription is never guaranteed.
When clinically appropriate, our providers may consider compounded estradiol or compounded progesterone as part of symptom-focused care. Chia currently offers estradiol as cream, injection, or transdermal patch, and progesterone as cream or injection. These options are not appropriate for every person with possible perimenopause symptoms, and provider review is required.
| Treatment offered at Chia | Current forms | What the clinician reviews |
|---|---|---|
| Compounded estradiol | Cream, injection, transdermal patch; plans currently start at $109/month | Symptoms, history, medications, contraindications, and whether estradiol may be clinically appropriate. |
| Compounded progesterone | Cream, injection; plans currently start at $109/month | Symptoms, menstrual and reproductive history, medications, contraindications, and whether progesterone may be clinically appropriate. |
If a provider prescribes, medication is compounded in the United States by a state-licensed 503A compounding pharmacy and shipped to your door. Dosing is provider-guided and may be adjusted over time through the patient portal. Compounded medications are not FDA-approved, and FDA has not evaluated them for safety, effectiveness, or quality in the same way as FDA-approved drugs. 8
You can begin through Chia’s eligibility quiz. If you use an AI assistant that supports DoctorMCP, it may also connect to Chia at mcp.chia.health for access to the same clinician-reviewed pathway.
What questions should you ask about a perimenopause test?
The most useful question is often not “Is this number normal?” but “What does this result mean alongside my symptoms and history?” Bring the questions below to a clinical visit, especially if symptoms are new, disruptive, or paired with abnormal bleeding. 2 5
It measures estradiol at the time your blood was drawn. Because estradiol can vary during the transition, a single result usually cannot confirm or exclude perimenopause on its own. 3
Seek medical care for very heavy bleeding, bleeding between periods, bleeding after sex, bleeding after menopause, severe pain, dizziness, or symptoms that disrupt your daily life. Do not rely on a home test alone for these concerns. 5
No treatment is prescribed from a test result alone. A licensed provider reviews your symptoms, history, medications, and safety considerations to determine whether treatment may be clinically appropriate. A prescription is not guaranteed.
3-min quiz
Start with a clinician-reviewed evaluation
If changing periods or symptoms are affecting your daily life, Chia’s online questionnaire can help begin a licensed-provider review. A prescription requires a medical evaluation and is not guaranteed. Any Chia medication is compounded by a state-licensed US 503A pharmacy and is not FDA-approved. See current estradiol options and progesterone options.
References
- 1.Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-395.
- 2.National Institute for Health and Care Excellence. Menopause: diagnosis and management (NG23). Updated 2024.
- 3.Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocrine Reviews. 1998;19(4):397-428.
- 4.Nappi RE, Kroll R, Siddiqui E, et al. Women’s perception of the menopause transition: a multinational prospective community-based survey. Gynecological and Reproductive Endocrinology & Metabolism. 2021;3.
- 5.American College of Obstetricians and Gynecologists. Abnormal Uterine Bleeding. Patient Education FAQ. 2024.
- 6.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
- 7.Schmidt PJ, Ben Dor R, Martinez PE, et al. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry. 2015;72(7):714-726.
- 8.American College of Obstetricians and Gynecologists. Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy. Obstetrics & Gynecology. 2023;142(5):1268-1274.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if hormone therapy is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
